March 23, 2026 - ET (Eastern Time, GMT-05:00)
- Stephen Rivera - Former Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
The CFO role is rapidly evolving from traditional financial oversight to being a strategic, data-driven business partner focused on organizational impact and performance.
Prominent CFOs will share examples of organizational initiatives and how these actions are reshaping finance to enhance business performance and growth.
*Additional CFO panelists to be confirmed and added to the agenda.
CPE Credits Available: 1.2
- Nick Cernese - Principal, Americas Healthcare & Life Sciences Finance Transformation Leader, Ernst & Young
- Robin Kramer - Executive Vice President and Chief Financial Officer, Biogen
Join an exclusive gathering of executive leaders for an intimate networking and benchmarking opportunity over lunch. Engage in high-level strategic conversations in a private setting designed to foster collaboration and knowledge exchange among top-tier decision makers.
- SEC Remarks
- FASB Remarks
- Town Hall Q&A
CPE Credits Available 1.8
- Nellie Debbeler - Deputy Technical Director, Financial Accounting Standards Board
- Andrea Willette, CPA - Professional Accounting Fellow, U.S. Securities and Exchange Commission
Strategic financial stewardship
Regulatory excellence and compliance
Digital/technology-driven transformation in accounting
Evolving leadership responsibilities and priorities
CPE Credits Available: 1.2
- Adam Pajakowski - Principal (Partner),, Crowe LLP
- Matthew Busch - Vice President of Finance, Chief Accounting Officer, Amgen
- Scott Godsoe - Executive Director, Assistant Corporate Controller, Vertex Pharmaceuticals
This session, featuring panelists from roles like CFO, Controller, CAO, and Treasurer will cover discussion elements on:
Their career journeys and the future-proof skill set, and experience needed for advancement
Key moments and talent development strategies within their organizations
CPE Credits Available 1.2
- Doreen Levine - Partner, Americas Financial Accounting Advisory Services Health Sciences Leader, Ernst & Young
- Kevin MacKay - Vice President, Global Technical Accounting Advisory Services & Policy, Pfizer
Revenue recognition
Inventory management
Cost accounting
R&D expense transition
FP&A
Internal controls and compliance
Systems & infrastructure
Tax considerations
Financial statement presentation
Investor relations
CPE Credits Available 1.2
- Kit Thorpe - Managing Partner, CFGI
- Jim Chopas - Chief Accounting Officer, Apellis Pharmaceuticals
- Ted Huizenga - Senior Vice President, Chief Accounting Officer, Ultragenyx Pharmaceutical
- Meagan Caldwell - Senior Director of Technical Accounting, Sumitomo Pharma America, Inc
- Frank Panaro - Director, Finance Valuation and Business Case Modeling, Bayer
Biotech Funding Landscape Evolution
Portfolio Optimization Across Development Stages
M&A and Licensing Strategy
R&D Investment Analysis
Regulatory Capital Requirements
Next-Generation Financial Technologies
Digital Health Investment Opportunities
CPE Credits Available 1.2
- Dana Hughes - Principal, Advisory, Transaction Strategy, KMPG